Speakers of ISM 2022
|  FMT 2022: Reorganization and Perspective Peter C. Konturek, President of ISM from the Teaching Hospital of the University of Jena, Germany | 
|  Microbiota & Microbiotal Medicine: Where We are Now & What’s Next? Marvin Edeas, Founder & Chairman of ISM, Institut Cochin, INSERM, Université de Paris, France | 
|  Microbiota and Drug Metabolism: Towards a Personalized Medicine Cristina Giaroni, University of Insubria, Italy | 
| Christoph Reinhardt, University Mainz, Germany | 
|  May the Microbiota of the Long-Lived Naked Mole-Rat Affect Human Health? Gerd Birkenmeier, University of Leipzig, Germany | 
|  Understanding the Heterogeneity of Host-associated Microbial Communities Lei Dai, Shenzhen Institutes of Advanced Technology, China | 
|  Gut Microbiota-Derived Extracellular Vesicles on Obesity, Diabetes and Metabolism Fermin I. Milagro, University of Navarra, Spain | 
| François Leulier, Université de Lyon, France | 
|  Precision Nutrition to Modulate Gut Microbiota in Reproductive Health and Pregnancy Annalisa Terranegra, Sidra Medical and Research Center, Qatar | 
|  Exploring a Healthy Human Gut Microbiota in a Mediterranean Cohort Andrés Moya, University of València, Spain | 
|  Interpreting Microbiomes Via Multi-omics for Precision Health Nathan Price, Thorne HealthTech, USA | 
|  Beneficial Effects of Natural Mineral Waters on Intestinal Inflammation and the Mucosa-Associated Microbiota Nicolas Barnich, Université Clermont Auvergne, France | 
|  Manipulating Fiber Polysaccharide Structure to Alter Targeting to Gut Microbiota Stephen Lindemann, Purdue University, USA | 
|  Short-chain Fatty Acids as Modulators of Redox Signaling in Health and Disease Carmen González-Bosch, Universitat de València, Spain | 
|  Proof-of-Principle Demonstration of Endogenous Circadian System and Circadian Misalignment Effects on Human Oral Microbiota Frank Scheer, Harvard Medical School, USA | 
|  The Probiotic Strain H. alvei HA4597 for Weight Loss Pierre Déchelotte, Rouen Normandy University, France | 
|  Probiotics and FMT as Add-On Therapies for Depression André Schmidt, University of Basel, Switzerland | 
|  Oral Microbial Dysbiosis and Oral Diseases Xin Xu, Sichuan University, China | 
|  Microbial Biomarkers to Predict Respiratory Infection Claire A. Woodall, University of Bristol, United Kingdom | 
| Matteo Serino, CRCN INSERM, France | 
| Maria Cecilia Giron, University of Padova, Italy | 
| Jarosław Biliński, Medical University of Warsaw, Poland | 
| Benoit Chassaing, Institut Cochin, France | 
| 
 | 
|  Influence of the Gut Microbiome in Ischemic Stroke Risk and Ischemic Stroke Outcome Miquel Lledós, Biomedical Research Institute Sant Pau, Spain | 
| Emrah Altindis, Biology Department Boston College, USA | 
|  Gene Editing and Microbiome Therapy Nahla Mansour, National Reseacrh Center, Egypt | 
|  Vaginal Microbiota and Dysbiosis: Recent Advances and Perspective Gary Ventolini, Texas Tech University Health Sciences Center, USA | 
|   | 
|   Sebastian Granica, Medical University of Warsaw, Poland | 
 
					



 Host-Microbes Mechanisms during E. coli Infections and Diet-induced Dysmetabolism
Host-Microbes Mechanisms during E. coli Infections and Diet-induced Dysmetabolism Cancer Therapy and Microbiota
Cancer Therapy and Microbiota Fecal Microbiota Transplantation as an Immunomodulatory and Anti-Infective Agent
Fecal Microbiota Transplantation as an Immunomodulatory and Anti-Infective Agent

 A Gut Commensal, Parabacteroides distasonis, and Type 1 Diabetes Onset
A Gut Commensal, Parabacteroides distasonis, and Type 1 Diabetes Onset







































